| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |